X-Ceptor Therapeutics, Inc.
San Diego
About X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. was acquired by Exelixis, Inc. X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. The company offers drug discovery platform for the nuclear receptor gene family; and drug candidates to treat cardiovascular and metabolic disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Website: x-ceptor.com
- Phone: (858)458-4500
Canonical: https://fsome.com/organization/x-ceptor-therapeutics-inc-637866 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.